12:00 AM
May 31, 2010
 |  BC Week In Review  |  Company News  |  Sales & Marketing

AdvanDx, Inverness sales and marketing update

AdvanDx launched the BinaxNOW PBP2a test in the U.S. to identify methicillin-resistant Staphylococcus aureus (MRSA). The test detects...

Read the full 67 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >